SCHEMBL7289441

SCHEMBL7289441

NC(=O)C(Cl)c1ccc(C(F)(F)F)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 2/20 0.49
CES1 P23141 2/20 0.49
KIF11 P52732 2/20 0.43
GSK3B P49841 2/20 0.43
ACP3 P15309 1/20 0.42
EPHX2 P34913 1/20 0.41
HTR3E A5X5Y0 1/20 0.41
HTR3B O95264 1/20 0.41
PLAU P00749 1/20 0.41
HTR3A P46098 1/20 0.41
HTR3D Q70Z44 1/20 0.41
HTR3C Q8WXA8 1/20 0.41
CNR2 P34972 2/20 0.41
AKR1C3 P42330 1/20 0.41
AKR1C2 P52895 1/20 0.41
KMT2A Q03164 1/20 0.41
SRD5A2 P31213 1/20 0.40
GRM8 O00222 1/20 0.39
GRM4 Q14833 1/20 0.39
CYP1A2 P05177 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14660908 0.82 CES2 (0.50) CES2CES1GSK3BACP3EPHX2
SCHEMBL1061611 0.80 CES2 (0.52) CES2CES1KIF11GSK3BACP3
SCHEMBL1398714 0.79 CES2 (0.47) CES2CES1GSK3BACP3EPHX2
SCHEMBL11755325 0.79 CES2 (0.66) CES2CES1GSK3BACP3KMT2A
SCHEMBL7279387 0.79 PNMT (0.53) CES2ACP3
SCHEMBL7470401 0.78 CES2 (0.65) CES2CES1KIF11GSK3BACP3
SCHEMBL953432 0.78 CES2 (0.50) CES2CES1KIF11GSK3BACP3
SCHEMBL28200284 0.78 CES2 (0.50) CES2CES1KIF11GSK3BACP3
SCHEMBL11840723 0.78 AKR1C3 (0.52) CES2CES1KIF11ACP3AKR1C3
SCHEMBL1395758 0.78 HDAC3 (0.44) CES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4567264-A ADRENERGIC BLOCKING AGENTS SYNTEX (U.S.A.) INC. (US) 1986-01-28 US disclosed
US-4558129-A Benzodioxanyl-hydroxyethylene-piperazinyl acetanilides which effect calcium entry and β-blockade SYNTEX (U.S.A.) INC. (US) 1985-12-10 US disclosed
US-4499100-A CARDIOUVASCULAR DISORDERS SYNTEX (U.S.A.) INC. (US) 1985-02-12 US disclosed
EP-0126449-A1 Cardioselective aryloxy- and arylthio-hydroxypropyl piperazinyl acetanilides wich affect calcium entry SYNTEX (U.S.A.) INC. (US) 1984-11-28 EP disclosed